Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia

Clinical trial NCT02417142 · COMPLETED

Trial details

NCT number: NCT02417142
Sponsor: University of Massachusetts, Worcester
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2014-09-01
Primary completion: 2019-07-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.